Noticias de COCP_US

Noticias del mercado

Últimas noticias sobre COCP_US — 150 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: COCP_US ✕ 150 resultados
10/06/2026 COCP_US — The Globe and Mail
Cocrystal Pharma Appoints New CEO to Lead Transition

Información detallada de precios de Cocrystal Pharma Inc (COCP-Q) de The Globe and Mail, incluidos gráficos y operaciones.

09/06/2026 COCP_US — Minichart
Cocrystal Pharma Appoints James Sapirstein as New CEO – Leadership Transition and Company Details
09/06/2026 COCP_US — Investing.com India
Cocrystal Pharma appoints James Sapirstein as CEO with new compensation package
09/06/2026 COCP_US — Investing.com ES ← EN
Cocrystal Pharma nombra a James Sapirstein como director ejecutivo con un nuevo paquete de compensación

Cocrystal Pharma appoints James Sapirstein as CEO with new compensation package

09/06/2026 COCP_US — TipRanks ES ← EN
Cocrystal Pharma nombra un nuevo director ejecutivo para liderar la transición

Cocrystal Pharma Appoints New CEO to Lead Transition

09/06/2026 COCP_US — Investing.com ES ← EN
Cocrystal Pharma nombra a James Sapirstein como director ejecutivo con un nuevo paquete de compensación

Cocrystal Pharma appoints James Sapirstein as CEO with new compensation package

09/06/2026 COCP_US — Stock Titan
James Sapirstein becomes CEO of Cocrystal Pharma (NASDAQ: COCP)
04/06/2026 COCP_US — newsline.com
Cocrystal Pharma Inc. (COCP) Q1 2026 Earnings: Wider-than-expected Loss as R&D Pipeline Progresses - Earnings Whisper Number
04/06/2026 COCP_US — The Business Journals
Cocrystal Pharma taps longtime biotech exec as its new CEO
03/06/2026 COCP_US — MarketScreener ES ← EN
Cocrystal Pharma Inc. planea nombrar a James Sapirstein como miembro de la junta directiva

Cocrystal Pharma Inc. Plans to Appoint James Sapirstein as A Member of the Board of Directors

03/06/2026 COCP_US — MarketScreener ES ← EN
Cocrystal Pharma Inc. anuncia cambios de director ejecutivo

Cocrystal Pharma Inc. Announces CEO Changes

03/06/2026 COCP_US — Investing.com ES ← EN
Cocrystal Pharma nombra a James Sapirstein nuevo director general Por Investing.com

Cocrystal Pharma names James Sapirstein as new CEO By Investing.com

03/06/2026 COCP_US — BioSpace ES ← EN
Cocrystal Pharma nombra a James Sapirstein, líder de la industria biofarmacéutica con amplia experiencia en desarrollo de antivirales, como director ejecutivo

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer

03/06/2026 COCP_US — GlobeNewswire ES ← EN
Cocrystal Pharma nombra a James Sapirstein, Biopharma

BOTHELL, Washington, 3 de junio de 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma Inc. (Nasdaq: COCP) ("Cocrystal" o la "Compañía"), una biotecnología en etapa clínica...

03/06/2026 COCP_US — Yahoo Finance
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
03/06/2026 COCP_US — Stock Titan
Cocrystal Pharma (COCP) CEO awarded 235,000 stock options under 2025 plan
03/06/2026 COCP_US — Stock Titan
Veteran antiviral leader James Sapirstein to head Cocrystal Pharma (NASDAQ: COCP)
03/06/2026 COCP_US — Stock Titan
Antiviral executive James Sapirstein takes helm at Cocrystal Pharma
03/06/2026 COCP_US — Stock Titan
Cocrystal Pharma (COCP) CEO James Sapirstein files initial Form 3
03/06/2026 COCP_US — TipRanks
Cocrystal Pharma Names New CEO to Drive Antiviral Pipeline

Página 1 de 8

keyboard_arrow_up